Studies on the mechanism of resistance to rapamycin in human cancer cells

被引:165
作者
Hosoi, H
Dilling, MB
Liu, LN
Danks, MK
Shikata, T
Sekulic, A
Abraham, RT
Lawrence, JC
Houghton, PJ
机构
[1] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
[2] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA
关键词
D O I
10.1124/mol.54.5.815
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rapamycin is a potent cytostatic agent that arrests cells in the G1 phase of the cell cycle. The relationships between cellular sensitivity to rapamycin, drug accumulation, expression of mammalian target of rapamycin (mTOR), and inhibition of growth factor activation of ribosomal p70S6 kinase (p70(S6k)) and dephosphorylation of pH acid stable protein I (eukaryotic initiation factor 4E binding protein) were examined. We show that some cell lines derived from childhood tumors are highly sensitive to growth inhibition by rapamycin, whereas others have high intrinsic resistance (>1000-fold). Accumulation and retention of [C-14]rapamycin were similar in sensitive and resistant cells, with all cells examined demonstrating a stable tight binding component. Western analysis showed levels of mTOR were similar in each cell line (<2-fold variation). The activity of p70S6k, activated downstream of mTOR, was similar in four cell lines (range, 11.75-41.8 pmol/2 x 10(6) cells/30 min), but activity was equally inhibited in cells that were highly resistant to rapamycin-induced growth arrest. Rapamycin equally inhibited serum-induced phosphorylation of pH acid stable protein I in Rh1 (intrinsically resistant) and sensitive Rh30 cells. In serum-fasted Rh30 and Rh1 cells, the addition of serum rapidly induced c-MYC (protein) levels. Rapamycin blocked induction in Rh30 cells but not in Rh1 cells. Serum-fasted Rh30/rapa10K cells, selected for high level acquired resistance to rapamycin, showed greater than or equal to 10-fold increased c-MYC compared with Rh30. These results suggest that the ability of rapamycin to inhibit c-MYC induction correlates with intrinsic sensitivity, whereas failure of rapamycin to inhibit induction or overexpression of c-MYC correlates with intrinsic and acquired resistance, respectively.
引用
收藏
页码:815 / 824
页数:10
相关论文
共 35 条
  • [1] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX
    BROWN, EJ
    ALBERS, MW
    SHIN, TB
    ICHIKAWA, K
    KEITH, CT
    LANE, WS
    SCHREIBER, SL
    [J]. NATURE, 1994, 369 (6483) : 756 - 758
  • [2] Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin
    Brunn, GJ
    Hudson, CC
    Sekulic, A
    Williams, JM
    Hosoi, H
    Houghton, PJ
    Lawrence, JC
    Abraham, RT
    [J]. SCIENCE, 1997, 277 (5322) : 99 - 101
  • [3] Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    Brunn, GJ
    Williams, J
    Sabers, C
    Wiederrecht, G
    Lawrence, JC
    Abraham, RT
    [J]. EMBO JOURNAL, 1996, 15 (19) : 5256 - 5267
  • [4] RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
    Burnett, PE
    Barrow, RK
    Cohen, NA
    Snyder, SH
    Sabatini, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) : 1432 - 1437
  • [5] RAPT1, A MAMMALIAN HOMOLOG OF YEAST TOR, INTERACTS WITH THE FKBP12 RAPAMYCIN COMPLEX
    CHIU, MI
    KATZ, H
    BERLIN, V
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12574 - 12578
  • [6] De Benedetti Arrigo, 1994, Molecular and Cellular Differentiation, V2, P347
  • [7] Dennis PB, 1996, MOL CELL BIOL, V16, P6242
  • [8] DIAS P, 1992, CANCER RES, V52, P6431
  • [9] DILLING MB, 1994, CANCER RES, V54, P903
  • [10] AUTONOMOUS GROWTH OF A HUMAN NEURO-BLASTOMA CELL-LINE IS MEDIATED BY INSULIN-LIKE GROWTH FACTOR-II
    ELBADRY, OM
    ROMANUS, JA
    HELMAN, LJ
    COOPER, MJ
    RECHLER, MM
    ISRAEL, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) : 829 - 839